XCELLIT
Live · Registered LIVE/REGISTRATION/Issued and Active
What this record means
The record shows that XCELLIT is a live, Principal Register trademark owned by LAKEFRONT BIOTHERAPEUTICS NV, registered on Feb 27 2024 after filing on Nov 5 2022. The registration covers software used as a medical monitoring and control tool for coordinating chimeric antigen receptor T‑cell therapy, related medical apparatus and instruments for cell and gene therapy production and analysis, cloud‑based SaaS offerings of that software, and medical services involving cell‑therapy evaluation and processing. A similar name would raise the closest record‑based concern if it were used for any of those medical‑technology products or services, but the record does not extend to unrelated goods or services. The prosecution history shows a standard examination with an office action and subsequent amendment before the mark entered the Principal Register; it never appeared on the Supplemental Register. The most recent meaningful event is the registration confirmation on Feb 27 2024, and the supplied history shows no oppositions, cancellations or other enforcement activity. I'd treat this as a meaningful concern for anyone planning a name in the same medical‑software or cell‑therapy space.
Informational only - not legal advice.Mark Trademark, Service Mark
| Drawing type | 4 - STANDARD CHARACTER MARK |
| Filing basis | Foreign Registration (§44(e)). |
| Status | Registered. The registration date is used to determine when post-registration maintenance documents are due. |
Key dates
| Application filed | Nov 05, 2022 |
| Published for opposition | Dec 12, 2023 |
| Registered (Principal) | Feb 27, 2024 |
| Status date | Feb 27, 2024 |
Goods & services
recorded software used as medical monitoring and control tool, specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and coordinates scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information; recorded software as a medical device (SaMD), specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and coordinates scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information; recorded computer software for use in medical decision support systems specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and coordinates scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information, and that supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment
Medical apparatus and instruments for use in apheresis, production of cell and gene therapies, testing, analysis, and quality assurance of cell and gene therapies, infusion of cell and gene therapies, and analysis of data gathered from the cell and gene therapy treatment; apparatus and instruments for cell analysis for medical use, namely, cancer and autoimmune disease treatment; medical apparatus in the nature of a system comprising an automated manufacturing device, reagents, software for the purpose of coordinating the treatment of patients, monitoring and conducting quality control on the testing of blood derived cells, supporting clinical decisions regarding the use of such cells for infusion and treatment, and the analysis of the results from such treatment
Software as a service (SAAS) services featuring software for medical monitoring and control specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information; providing temporary use of nondownloadable, cloud-based software featuring software for medical monitoring and control specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and coordinates scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information; software as a service (SAAS) services for use in medical decision support systems, specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and coordinates scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information, and that supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment; providing temporary use of non-downloadable, cloud-based software featuring software for use in medical decision support systems, specifically, software that coordinates the treatment of patients, that monitors and controls manufacture, supply, workflow, and coordinates scheduling of delivery of chimerin antigen receptor T-cell therapy, that records patient status, treatment, and vitals, that gathers, stores, sends, and makes accessible patient data and treatment information, and that supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment; Providing information about the results of clinical trials for pharmaceutical products; scientific research in the nature of conducting clinical trials; Providing information about the results of clinical trials; evaluation pharmaceutical products in the nature of product quality testing; providing information regarding the product quality testing and clinical trials of pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical product quality testing; advisory and consultancy services in the field of medical and pharmaceutical product development
Medical services; medical and pharmaceutical evaluation of medical and pharmaceutical products to determine effectiveness and suitability for use in treatment of specific medical conditions; medical services, namely, cell therapy services; Medical services relating to the removal, treatment and processing of human cells
Owner & representation
| Owner | LAKEFRONT BIOTHERAPEUTICS NV |
| Address | SCHALIËNHOEVEDREEF 20 BOX T, MECHELEN BELGIUM 2800 |
| Entity | CORPORATION - organized in BELGIUM |
| Attorney of record | Alexandra MacKay |
| Correspondent | Alexandra MacKay |
| Attorney email | a********@*****.com |
| Correspondent email | 3 emails |
| Correspondent phone | 6********0 |
| Correspondent address | NASHVILLE, TENNESSEE |